Trial Profile
A Non-Interventional Follow-Up to the VELOUR Study (Multicentre International Study of Aflibercept Versus Placebo in Combination With FOLFIRI for Metastatic Colorectal Cancer) - Translational Research
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results (n=666) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 08 Feb 2013 New trial record